Chemcrux Enterprises Limited (BOM:540395)
India · Delayed Price · Currency is INR 85.70
-0.91 (-1.05%)
At close: Aug 19, 2026
Chemcrux Enterprises Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 860.81 | 806.46 | 700.1 | 784.65 | 951.52 | 952.71 |
Other Revenue | - | - | - | -0 | - | - |
| 860.81 | 806.46 | 700.1 | 784.65 | 951.52 | 952.71 | |
Revenue Growth | 24.03% | 15.19% | -10.78% | -17.54% | -0.12% | 78.64% |
Cost of Revenue | 345.82 | 325.41 | 286.1 | 324.54 | 437.64 | 502.04 |
Gross Profit | 514.99 | 481.05 | 414 | 460.11 | 513.89 | 450.66 |
Selling, General & Admin | 101.99 | 96.31 | 86.36 | 88.92 | 79.66 | 63.37 |
Other Operating Expenses | 290.91 | 273.37 | 233.02 | 234.81 | 218.54 | 176.28 |
Operating Expenses | 440.31 | 417.01 | 351.44 | 346.57 | 318.57 | 255.53 |
Operating Income | 74.68 | 64.04 | 62.56 | 113.54 | 195.32 | 195.14 |
Interest Expense | -29.25 | -31.47 | -17.38 | -6.47 | -4.55 | -1.38 |
Interest & Investment Income | - | - | 7.05 | 3.92 | 2.88 | 0.92 |
Earnings From Equity Investments | - | - | -0.05 | - | - | - |
Currency Exchange Gain (Loss) | - | - | 1.88 | 2.13 | 1.92 | 2.26 |
Other Non Operating Income (Expenses) | 16.9 | 20.25 | 0.57 | -0.55 | -3.05 | 0.05 |
EBT Excluding Unusual Items | 62.33 | 52.82 | 54.63 | 112.56 | 192.51 | 196.98 |
Gain (Loss) on Sale of Investments | - | - | 2.38 | 3.44 | 3.8 | 2.11 |
Gain (Loss) on Sale of Assets | - | - | 0.6 | - | 0.17 | 0.39 |
Asset Writedown | - | - | - | -1.68 | - | - |
Pretax Income | 62.33 | 52.82 | 57.61 | 114.32 | 196.48 | 199.48 |
Income Tax Expense | 20.9 | 15.51 | 18.47 | 29.87 | 52.9 | 50.89 |
Net Income | 41.43 | 37.31 | 39.13 | 84.44 | 143.58 | 148.59 |
Net Income to Common | 41.43 | 37.31 | 39.13 | 84.44 | 143.58 | 148.59 |
Net Income Growth | 49.68% | -4.66% | -53.66% | -41.19% | -3.37% | 66.32% |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Change | -2.30% | -0.03% | - | - | - | 0.00% |
EPS (Basic) | 2.83 | 2.52 | 2.64 | 5.70 | 9.70 | 10.03 |
EPS (Diluted) | 2.83 | 2.52 | 2.64 | 5.70 | 9.70 | 10.03 |
EPS Growth | 53.20% | -4.54% | -53.68% | -41.21% | -3.33% | 66.26% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 87.07 | -8.03 | -79.46 | 36.51 | 45.57 |
Free Cash Flow Per Share | - | 5.88 | -0.54 | -5.37 | 2.47 | 3.08 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 2.000 | 2.000 |
Dividend Growth | - | 0% | 0% | -50.00% | 0% | 199.98% |
Gross Margin | 59.83% | 59.65% | 59.13% | 58.64% | 54.01% | 47.30% |
Operating Margin | 8.68% | 7.94% | 8.94% | 14.47% | 20.53% | 20.48% |
Profit Margin | 4.81% | 4.63% | 5.59% | 10.76% | 15.09% | 15.60% |
Free Cash Flow Margin | - | 10.80% | -1.15% | -10.13% | 3.84% | 4.78% |
EBITDA | 126.14 | 111.37 | 93.36 | 135.14 | 214.41 | 209.66 |
EBITDA Margin | 14.65% | 13.81% | 13.33% | 17.22% | 22.53% | 22.01% |
D&A For EBITDA | 51.46 | 47.33 | 30.8 | 21.61 | 19.1 | 14.53 |
EBIT | 74.68 | 64.04 | 62.56 | 113.54 | 195.32 | 195.14 |
EBIT Margin | 8.68% | 7.94% | 8.94% | 14.47% | 20.53% | 20.48% |
Effective Tax Rate | 33.52% | 29.37% | 32.07% | 26.13% | 26.92% | 25.51% |
Revenue as Reported | 877.71 | 826.71 | 714.97 | 798.01 | 962.05 | 962.69 |
Advertising Expenses | - | - | 0.72 | 0.63 | 0.53 | 0.2 |